RESEARCH-USE BIOSIMILAR ANTIBODY

Lodelcizumab

Monoclonal antibody · IgG1

PCSK9IgG1RUO

Lodelcizumab is a monoclonal antibody targeting PCSK9. Lodelcizumab can be used for the research of hypercholesterolemia.

TARGETPCSK9
YMonoclonal antibody
CATALOGSC-BS-414
CATALOG NUMBERSC-BS-414
MOLECULAR WEIGHTApprox. 145.6 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Lodelcizumab is a monoclonal antibody targeting PCSK9. Lodelcizumab can be used for the research of hypercholesterolemia.

Lodelcizumab is a recombinant research-use antibody directed against PCSK9.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Lodelcizumab | StellaCyte